Weather Conditions & Migraine Attacks: Is there a relationship?
Posted on April 18 2025,
Weather Conditions & Migraine Attacks
Meta-analysis of 31 studies
Journal of Neurology - April 2025
Li S, Liu Q, Ma M, Fang J, He L
Key Research Findings:
Weather Changes
Significant trigger factor for migraine attacks (RD = 0.47)
Temperature
Associated with migraine attacks (OR = 1.15)
Ambient Pressure
Associated with migraine attacks (OR = 1.07)
Air Pollutants Associated with Migraine Attacks
OR = 1.07
OR = 1.08
OR = 1.04
OR = 1.12
OR = 1.08
OR = 1.02*
*Not statistically significant
Conclusion
This meta-analysis found that weather conditions, especially temperature and ambient pressure changes as well as increased levels of certain air pollutants (PM10, PM2.5, NO2, CO, and O3), are significantly associated with triggering migraine attacks.
What This Means For Migraine Patients
Weather Forecasting
Consider using weather forecasting apps that specifically track migraine triggers. Being prepared for upcoming weather changes could help you take preventive measures before an attack occurs.
Air Quality Monitoring
Air pollutants such as PM10, PM2.5, NO2, CO, and O3 are linked to increased migraine attacks. Consider monitoring local air quality indexes and limiting outdoor activities on high-pollution days.
Temperature Control
Sudden temperature changes can trigger migraine attacks. Maintain consistent indoor temperatures and dress appropriately when heading outdoors during extreme weather conditions.
Pressure Changes
Barometric pressure changes may trigger migraine attacks. Consider tracking your symptoms alongside pressure changes to identify your personal threshold and prepare accordingly.
Thu, Apr 24, 25
Clinical Predictors for Efficacy of Erenumab (Aimovig) for Migraine
Discover key predictors of Aimovig (erenumab) response in migraine patients. This REFORM study reveals which patients benefit most from CGRP therapy and why timing matters. Evidence-based insights for better treatment...
Read MoreWed, Apr 23, 25
Effectiveness and Tolerability of Atogepant (Qulipta) in the Prevention of Migraine
STAR study shows atogepant (Qulipta) effectively reduces migraine days by 56.6% in real-world clinical practice, even for patients with previous treatment failures. Learn about this breakthrough.
Read MoreWed, Apr 23, 25
Impact of Visual Stimulus Complexity on Associative Learning in Migraine Patients
Groundbreaking research reveals how migraine patients process visual information differently. This 2025 study found that migraine patients take longer to process simple visual stimuli compared to complex images, which is...
Read More